Stroke Patterns, Etiology, and Prognosis in Patients with Diabetes Mellitus
Neurol 62:1558-1562, Karapanayiotides,Th.,et al, 2004
Infarct Patterns in Atherosclerotic Middle Cerebral Artery Versus Internal Carotid Artery Disease
Neurol 62:1291-1296, Lee,P.H.,et al, 2004
A Paralysed Thumb
Lancet 363:1364, Sudo,K.,et al, 2004
Diffusion-Weighted Magnetic Resonance Imaging in Internal Carotid Artery Dissection
Arch Neurol 61:510-512, Koch,S.,et al, 2004
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004
Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis
Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004
Delusional State Following Acute Stroke
Neurol 62:110-113, Kumral,E. & Ozturk,O., 2004
Amyloid Myopathy Presenting with Distal Atrophic Weakness
Muscle Nerve 29:605-609, Smestad, C.,et al, 2004
Association of Ischemic Lesion Patterns on Early Diffusion-Weighted Imaging with TOAST Stroke Subtypes
Arch Neurol 60:1730-1734, Kang,D.,et al, 2003
The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003
Stroke Location, Characterization, Severity, and Outcome in Mitral vs Aortic Valve Endocarditis
Neurol 61:1341-1346, Anderson,D.J.,et al, 2003
Isolated Shoulder Paresis Caused by a Small Cortical Infarction
Neurol 61:1457, Komatsu,K.,et al, 2003
Spinal Dural Arteriovenous Fistulas: Clinical Features in 80 Patients
JNNP 74:1438-1440, Jellema,K.,et al, 2003
Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003
Bickerstaff's Brainstem Encephalitis: Clinical Features of 62 Cases and a Subgroup Associated with Guillain-Barre Syndrome
Brain 126:2279-2290, Odaka,M.,et al, 2003
Acute Guillain-Barre-like Polyradiculoneuritis Revealing Acute Systemic Lupus Erythematosus: Two Case Studies and Review of the Literature
Rev Neurol 159:300-306, Benhaddou,A.,et al, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003
Emergency Intubation for Respiratory Failure in Guillain-Barre Syndrome
Arch Neurol 60:947-948, Wijdicks,E.F.M.,et al, 2003
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003
Multiple Sclerosis Presenting as Lower Motor Neuron Wasting and Weakness of the Distal Upper Extremity
Neurol 61:1303-1304, Chong,P.S.T.,et al, 2003
Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003
The Impact of Delays in Computed Tomography of the Brain on the Accuracy of Diagnosis and Subsequent Management in Patients with Minor Stroke
JNNP 74:77-81, Wardlaw,J.M.,et al, 2003
The Morbidity of Guillain-Barre Syndrome Admitted to the Intensive Care Unit
Neurol 60:17-21, Henderson,R.D.,et al, 2003
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003
POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003
Reappraisal of Early CT signs to Predict the Arterial Occlusion Site in Acute Embolic Stroke
JNNP 74:649-653, Koga,M.,et al, 2003
Primary Lateral Sclerosis
Neurol 60:1258-1265, Zhai,P.,et al, 2003
Pure Dysarthria Due to Small Cortical Stroke
Neurol 60:1178-1180, Kim,J.S.,et al, 2003
Cortical Laminar Necrosis in Brain Infarcts: Serial MRI
Neuroradiology 45:283-288, Siskas, N.,et al, 2003
Antiphospholipid Syndrome and Multiple Ischemic Strokes in a Patient with Myasthenia Gravis
Kurume Med J 49:211-216, Kaji, M.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Out of Africa, Trypanosomiasis
NEJM 347:749-753, Sahlas,D.J.,et al, 2002
Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002
Guillain-Barre Syndrome Following Acute Falciparum Malaria
Neurol 59:1281-1283, Sakrab,T.O.,et al, 2002
Poliomyelitis Due to West Nile Virus
NEJM 347:1280-1281, Glass,J.D.,et al, 2002
West Nile Virus Encephalitis
NEJM 347:1225-1226, Peterson,L.R.,et al, 2002
A Poliomyelitis-like Syndrome from West Nile Virus Infection
NEJM 347:1279-1280, Leis,A.A., et al, 2002
Tick Paralysis in Children
Neurol 59:1088-1090, Vedanarayanan,V.V.,et al, 2002
Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002
A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002
A Reversible Paralysis
Lancet 360:1160, Maury,E.,et al, 2002
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Middle Cerebral Artery Stenosis Is a Major Clinical Determinant in Striatocapsular Small, Deep Infarction
Arch Neurol 59:259-263, Bang,O.Y.,et al, 2002